17 results on '"Okitolonda Wemakoy, Emile"'
Search Results
2. Risk Factors for Ebola Exposure in Health Care Workers in Boende, Tshuapa Province, Democratic Republic of the Congo.
- Author
-
Doshi, Reena H, Hoff, Nicole A, Bratcher, Anna, Mukadi, Patrick, Gadoth, Adva, Nicholson, Bradly P, Williams, Russell, Mukadi, Daniel, Mossoko, Matthias, Wasiswa, Joseph, Mwanza, Alexis, Sinai, Cyrus, Alfonso, Vivian H, Shah, Rupal, Bramble, Matthew S, Ilunga-Kebela, Benoit, Okitolonda-Wemakoy, Emile, Muyembe-Tamfum, Jean Jacques, and Rimoin, Anne W
- Subjects
EBOLA virus disease ,IMMUNOGLOBULINS ,EBOLA virus ,EPIDEMICS ,RESEARCH funding - Abstract
Background: Health care workers (HCW) are more likely to be exposed to Ebola virus (EBOV) during an outbreak compared to people in the general population due to close physical contact with patients and potential exposure to infectious fluids. However, not all will fall ill. Despite evidence of subclinical and paucisymptomatic Ebola virus disease (EVD), prevalence and associated risk factors remain unknown.Methods: We conducted a serosurvey among HCW in Boende, Tshuapa Province, Democratic Republic of Congo. Human anti-EBOV glycoprotein IgG titers were measured using a commercially available ELISA kit. We assessed associations between anti-EBOV IgG seroreactivity, defined as ≥2.5 units/mL, and risk factors using univariable and multivariable logistic regression. Sensitivity analyses explored a more conservative cutoff, >5 units/mL.Results: Overall, 22.5% of HCWs were seroreactive for EBOV. In multivariable analyses, using any form of personal protective equipment when interacting with a confirmed, probable, or suspect EVD case was negatively associated with seroreactivity (adjusted odds ratio, 0.23; 95% confidence interval, .07-.73).Discussion: Our results suggest high exposure to EBOV among HCWs and provide additional evidence for asymptomatic or minimally symptomatic EVD. Further studies should be conducted to determine the probability of onward transmission and if seroreactivity is associated with immunity. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
3. Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013–2014.
- Author
-
Cheng, Alvan, Ghanem-Uzqueda, Angie, Hoff, Nicole A., Ashbaugh, Hayley, Doshi, Reena H., Mukadi, Patrick, Budd, Roger, Higgins, Stephen G., Randall, Christina, Gerber, Sue, Kabamba, Michel, Ngoie Mwamba, Guilluame, Okitolonda-Wemakoy, Emile, Muyembe-Tanfum, Jean Jacques, and Rimoin, Anne W.
- Subjects
RUBELLA ,TETANUS ,CHICKENPOX ,SCHOOL children ,VACCINATION coverage ,TETANUS vaccines ,DEMOGRAPHIC surveys ,RESIDENTIAL areas - Abstract
Background: Tetanus is a potentially fatal disease that is preventable through vaccination. While the Democratic Republic of the Congo (DRC) has continued to improve implementing routine vaccination activities throughout the country, they have struggled to maintain high childhood vaccine coverage. This study aims to examine the seroprevalence of tetanus in children 6 to 59 months to identify areas for intervention and improvement of vaccination coverage. Methods: In collaboration with the 2013–2014 Demographic and Health Survey, we assessed the seroprevalence of tetanus antibodies among children in the DRC. Dried blood spot samples collected from children 6–59 months of age were processed using a prototype DYNEX Multiplier® chemiluminescent automated immunoassay instrument with a multiplex measles, mumps, rubella, varicella and tetanus assay. Multivariable logistic regression was used to determine factors associated with tetanus vaccination and seroprotection. Results: Overall, 36.1% of children 6–59 months of age reported receiving at least 1 dose of tetanus vaccine while 28.7% reported receiving 3 doses; tetanus seroprotection was 40%. Increasing age in children was associated with decreased tetanus seroprotection, but increased number tetanus vaccinations received. Factors related to increased tetanus seroprotection included number of children in the household, wealth index of the family, urban residence compared to rural, level of maternal education, and province and geography. Conclusions: Our findings in this nationally representative sample indicate that serology biomarkers may help identify children who are not fully immunized to tetanus more accurately than reported vaccination. While children may be captured for routine immunization activities, as children age, decreasing seroprevalence may indicate additional need to bolster routine vaccination activities and documentation of vaccination in school aged children. Additionally, the study highlights gaps in rural residential areas and vaccination coverage based on maternal education, indicating that policies targeting maternal education and awareness could improve the coverage and seroprevalence of tetanus antibodies in the DRC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey.
- Author
-
Alfonso, Vivian H., Voorman, Arie, Hoff, Nicole A., Weldon, William C., Gerber, Sue, Gadoth, Adva, Halbrook, Megan, Goldsmith, Amelia, Mukadi, Patrick, Doshi, Reena H., Ngoie-Mwamba, Guillaume, Fuller, Trevon L., Okitolonda-Wemakoy, Emile, Muyembe-Tamfum, Jean-Jacques, and Rimoin, Anne W.
- Abstract
Background: Vaccination efforts to eradicate polio currently focus on children under 5 years of age, among whom most cases of poliomyelitis still occur. However, in the Democratic Republic of the Congo (DRC), an outbreak of wild poliovirus type 1 occurred in 2010-2011 in which 16% of cases occurred among adults; in a related outbreak in the neighboring Republic of Congo, 75% of cases occurred among the same adult age-group. Given that infected adults may transmit poliovirus, this study was designed to assess adult immunity against polioviruses.Methods: We assessed poliovirus seroprevalence using dried blood spots from 5,526 adults aged 15-59 years from the 2013-2014 Demographic and Health Survey in the DRC.Results: Among adults in the DRC, 74%, 72%, and 57% were seropositive for neutralizing antibodies for poliovirus types 1, 2, and 3, respectively. For all three serotypes, seroprevalence tended to be higher among older age groups, those living in households with more children, and among women.Conclusions: Protection against poliovirus is generally low among adults in the DRC, particularly for type 3 poliovirus. The lack of acquired immunity in adults suggests a potentially limited poliovirus circulation over the lifetime of those surveyed (spanning 1954 through 2014) and transmission of vaccine-derived poliovirus in this age group while underscoring the risk of these outbreaks among adults in the DRC. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
5. Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
- Author
-
Bratcher, Anna, Hoff, Nicole A., Doshi, Reena H., Gadoth, Adva, Halbrook, Megan, Mukadi, Patrick, Musene, Kamy, Ilunga-Kebela, Benoit, Spencer, D'Andre, Bramble, Matthew S., McIlwan, David, Kelly, J. Daniel, Mukadi, Daniel, Kingebeni, Placide Mbala, Ahuka, Steve, Okitolonda-Wemakoy, Emile, Muyembe-Tamfum, Jean-Jacques, and Rimoin, Anne W.
- Subjects
EBOLA virus disease ,EBOLA virus ,VIRAL antibodies ,MEDICAL personnel ,SEROPREVALENCE ,FOOD poisoning - Abstract
Background: Ebola virus (EBOV) is a zoonotic filovirus spread through exposure to infected bodily fluids of a human or animal. Though EBOV is capable of causing severe disease, referred to as Ebola Virus Disease (EVD), individuals who have never been diagnosed with confirmed, probable or suspected EVD can have detectable EBOV antigen-specific antibodies in their blood. This study aims to identify risk factors associated with detectable antibody levels in the absence of an EVD diagnosis. Methodology: Data was collected from September 2015 to August 2017 from 1,366 consenting individuals across four study sites in the DRC (Boende, Kabondo-Dianda, Kikwit, and Yambuku). Seroreactivity was determined to EBOV GP IgG using Zaire Ebola Virus Glycoprotein (EBOV GP antigen) ELISA kits (Alpha Diagnostic International, Inc.) in Kinshasa, DRC; any result above 4.7 units/mL was considered seroreactive. Among the respondents, 113 (8.3%) were considered seroreactive. Several zoonotic exposures were associated with EBOV seroreactivity after controlling for age, sex, healthcare worker status, location, and history of contact with an EVD case, namely: ever having contact with bats, ever having contact with rodents, and ever eating non-human primate meat. Contact with monkeys or non-human primates was not associated with seroreactivity. Conclusions: This analysis suggests that some zoonotic exposures that have been linked to EVD outbreaks can also be associated with EBOV GP seroreactivity in the absence of diagnosed EVD. Future investigations should seek to clarify the relationships between zoonotic exposures, seroreactivity, asymptomatic infection, and EVD. Author summary: Ebola virus (EBOV) is spread through exposure to infected bodily fluids of a human or animal. While EBOV can lead to a severe disease, Ebola Virus Disease (EVD), it is possible for individuals to have anti-EBOV antibodies without ever getting sick with EVD. Seroreactivity (the detection of antigen-specific antibodies) suggests that that person has been exposed to EBOV or a similar virus in the past. Our study looked for seroreactive individuals who have never received an EVD diagnosis in four sites across the Democratic Republic of the Congo. Then we checked if animal exposures previously linked to EVD were more common among seroreactive individuals than non-seroreactive individuals. Among respondents from all four sites, 113 (8.3%) were seroreactive to EBOV. Additionally, contact with bats, rodents, and eating non-human primate meat were associated with seroreactivity, indicating these factors may be predictors of undocumented EBOV exposure events. These findings show that some EVD risk factors may be associated with EBOV seroreactivity without EVD diagnosis. Future research is needed to clarify the relationships between zoonotic exposures, seroreactivity, asymptomatic infection, and EVD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. The Impact of Different Types of Violence on Ebola Virus Transmission During the 2018-2020 Outbreak in the Democratic Republic of the Congo.
- Author
-
Kelly, John Daniel, Wannier, Sarah Rae, Sinai, Cyrus, Moe, Caitlin A, Hoff, Nicole A, Blumberg, Seth, Selo, Bernice, Mossoko, Mathais, Chowell-Puente, Gerardo, Jones, James Holland, Okitolonda-Wemakoy, Emile, Rutherford, George W, Lietman, Thomas M, Muyembe-Tamfum, Jean Jacques, Rimoin, Anne W, Porco, Travis C, and Richardson, Eugene T
- Subjects
EBOLA virus ,EBOLA virus disease ,VIOLENCE ,PUBLIC demonstrations ,REGRESSION analysis - Abstract
Background: Our understanding of the different effects of targeted versus nontargeted violence on Ebola virus (EBOV) transmission in Democratic Republic of the Congo (DRC) is limited.Methods: We used time-series data of case counts to compare individuals in Ebola-affected health zones in DRC, April 2018-August 2019. Exposure was number of violent events per health zone, categorized into Ebola-targeted or Ebola-untargeted, and into civilian-induced, (para)military/political, or protests. Outcome was estimated daily reproduction number (Rt) by health zone. We fit linear time-series regression to model the relationship.Results: Average Rt was 1.06 (95% confidence interval [CI], 1.02-1.11). A mean of 2.92 violent events resulted in cumulative absolute increase in Rt of 0.10 (95% CI, .05-.15). More violent events increased EBOV transmission (P = .03). Considering violent events in the 95th percentile over a 21-day interval and its relative impact on Rt, Ebola-targeted events corresponded to Rt of 1.52 (95% CI, 1.30-1.74), while civilian-induced events corresponded to Rt of 1.43 (95% CI, 1.21-1.35). Untargeted events corresponded to Rt of 1.18 (95% CI, 1.02-1.35); among these, militia/political or ville morte events increased transmission.Conclusions: Ebola-targeted violence, primarily driven by civilian-induced events, had the largest impact on EBOV transmission. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
7. Seroreactivity against Marburg or related filoviruses in West and Central Africa.
- Author
-
Steffen, Imke, Lu, Kai, Hoff, Nicole A., Mulembakani, Prime, Okitolonda Wemakoy, Emile, Muyembe-Tamfum, Jean-Jacques, Ndembi, Nicaise, Brennan, Catherine A., Hackett Jr., John, Switzer, William M., Saragosti, Sentob, Mbensa, Guy O., Laperche, Syria, Rimoin, Anne W., and Simmons, Graham
- Published
- 2020
- Full Text
- View/download PDF
8. Prenatal chlamydial, gonococcal, and trichomonal screening in the Democratic Republic of Congo for case detection and management.
- Author
-
Gadoth, Adva, Shannon, Chelsea L, Hoff, Nicole A, Mvumbi, Gisèle, Musene, Kamy, Okitolonda-Wemakoy, Emile, Hoffman, Risa M, Rimoin, Anne W, and Klausner, Jeffrey D
- Subjects
SEXUALLY transmitted diseases ,PREGNANT women ,NUCLEIC acid amplification techniques ,GONORRHEA ,CHLAMYDIA trachomatis ,NEISSERIA gonorrhoeae ,GONORRHEA diagnosis ,GONORRHEA prevention ,CHLAMYDIA infection prevention ,COMMUNICABLE disease epidemiology ,COMMUNICABLE disease diagnosis ,CHLAMYDIA infection diagnosis ,PROTOZOA ,PILOT projects ,RESEARCH ,TRICHOMONAS vaginalis ,CROSS-sectional method ,RESEARCH methodology ,MEDICAL screening ,EVALUATION research ,MEDICAL cooperation ,IMIDAZOLES ,PATIENTS' attitudes ,METRONIDAZOLE ,TREATMENT effectiveness ,COMPARATIVE studies ,NEISSERIA ,PREGNANCY complications ,RESEARCH funding ,AZITHROMYCIN ,PRENATAL care ,VERTICAL transmission (Communicable diseases) ,ANTIBIOTICS ,CHLAMYDIA infections - Abstract
Prenatal Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) infections are associated with adverse birth outcomes. As rapid diagnostic tests become available, it is important to evaluate prenatal sexually transmitted infection (STI) prevalence, as well as the acceptability and feasibility of prenatal screening programs. We recruited 371 pregnant women from four clinics in Kisantu Health Zone, Democratic Republic of Congo (DRC) from October 2016 to March 2017. Trained clinicians collected cervical swabs, and samples were tested by nucleic acid amplification for CT, NG, and TV using a GeneXpert® system. Those testing positive for an STI were treated and asked to return after 4–8 weeks for tests-of-cure. Screening for STIs was widely accepted (99%). STI prevalence at baseline was CT, 3.2%; NG, 1.5%; and TV, 14%; treatment completion was 97%. Symptoms were reported among 34% of STI-positive women at baseline, compared with 37% of STI-negative women. Upon first test-of-cure, 100% of returning women were cured of CT (n = 10) and NG (n = 5), but only 47% were cured of TV. This study demonstrates the feasibility of implementing diagnostic STI testing for case detection and treatment among expectant mothers in DRC, with implications for maternal and birth outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. Association of Previous Measles Infection With Markers of Acute Infectious Disease Among 9- to 59-Month-Old Children in the Democratic Republic of the Congo.
- Author
-
Ashbaugh, Hayley R, Cherry, James D, Hoff, Nicole A, Doshi, Reena H, Alfonso, Vivian H, Gadoth, Adva, Mukadi, Patrick, Higgins, Stephen G, Budd, Roger, Randall, Christina, Okitolonda-Wemakoy, Emile, Muyembe-Tamfum, Jean Jacques, Gerber, Sue K, and Rimoin, Anne W
- Subjects
DIARRHEA ,MEASLES prevention ,COUGH -- Risk factors ,BIOMARKERS ,BLOOD testing ,COMMUNICABLE diseases ,CONFIDENCE intervals ,FEVER ,IMMUNOASSAY ,IMMUNOGLOBULINS ,IMMUNOSUPPRESSION ,INTERVIEWING ,MEASLES ,MEASLES vaccines ,RISK assessment ,SURVEYS ,ACUTE diseases ,ODDS ratio ,DISEASE risk factors ,CHILDREN - Abstract
Background Transient immunosuppression and increased susceptibility to other infections after measles infection is well known, but recent studies have suggested the occurrence of an "immune amnesia" that could have long-term immunosuppressive effects. Methods We examined the association between past measles infection and acute episodes of fever, cough, and diarrhea among 2350 children aged 9 to 59 months whose mothers were selected for interview in the 2013–2014 Democratic Republic of the Congo (DRC) Demographic and Health Survey (DHS). Classification of children who had had measles was completed using maternal recall and measles immunoglobulin G serostatus obtained via dried-blood-spot analysis with a multiplex immunoassay. The association with time since measles infection and fever, cough, and diarrhea outcomes was also examined. Results The odds of fever in the previous 2 weeks were 1.80 (95% confidence interval [CI], 1.25–2.60) among children for whom measles was reported compared to children with no history of measles. Measles vaccination demonstrated a protective association against selected clinical markers of acute infectious diseases. Conclusion Our results suggest that measles might have a long-term effect on selected clinical markers of acute infectious diseases among children aged 9 to 59 months in the DRC. These findings support the immune-amnesia hypothesis suggested by others and underscore the need for continued evaluation and improvement of the DRC's measles vaccination program. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019.
- Author
-
Worden, Lee, Wannier, Rae, Hoff, Nicole A., Musene, Kamy, Selo, Bernice, Mossoko, Mathias, Okitolonda-Wemakoy, Emile, Muyembe Tamfum, Jean Jacques, Rutherford, George W., Lietman, Thomas M., Rimoin, Anne W., Porco, Travis C., and Kelly, J. Daniel
- Subjects
EBOLA virus disease ,DISEASE outbreaks ,VACCINATION ,BRANCHING processes ,HEMORRHAGIC fever - Abstract
Background: As of February 25, 2019, 875 cases of Ebola virus disease (EVD) were reported in North Kivu and Ituri Provinces, Democratic Republic of Congo. Since the beginning of October 2018, the outbreak has largely shifted into regions in which active armed conflict has occurred, and in which EVD cases and their contacts have been difficult for health workers to reach. We used available data on the current outbreak, with case-count time series from prior outbreaks, to project the short-term and long-term course of the outbreak. Methods: For short- and long-term projections, we modeled Ebola virus transmission using a stochastic branching process that assumes gradually quenching transmission rates estimated from past EVD outbreaks, with outbreak trajectories conditioned on agreement with the course of the current outbreak, and with multiple levels of vaccination coverage. We used two regression models to estimate similar projection periods. Short- and long-term projections were estimated using negative binomial autoregression and Theil-Sen regression, respectively. We also used Gott’s rule to estimate a baseline minimum-information projection. We then constructed an ensemble of forecasts to be compared and recorded for future evaluation against final outcomes. From August 20, 2018 to February 25, 2019, short-term model projections were validated against known case counts. Results: During validation of short-term projections, from one week to four weeks, we found models consistently scored higher on shorter-term forecasts. Based on case counts as of February 25, the stochastic model projected a median case count of 933 cases by February 18 (95% prediction interval: 872–1054) and 955 cases by March 4 (95% prediction interval: 874–1105), while the auto-regression model projects median case counts of 889 (95% prediction interval: 876–933) and 898 (95% prediction interval: 877–983) cases for those dates, respectively. Projected median final counts range from 953 to 1,749. Although the outbreak is already larger than all past Ebola outbreaks other than the 2013–2016 outbreak of over 26,000 cases, our models do not project that it is likely to grow to that scale. The stochastic model estimates that vaccination coverage in this outbreak is lower than reported in its trial setting in Sierra Leone. Conclusions: Our projections are concentrated in a range up to about 300 cases beyond those already reported. While a catastrophic outbreak is not projected, it is not ruled out, and prevention and vigilance are warranted. Prospective validation of our models in real time allowed us to generate more accurate short-term forecasts, and this process may prove useful for future real-time short-term forecasting. We estimate that transmission rates are higher than would be seen under target levels of 62% coverage due to contact tracing and vaccination, and this model estimate may offer a surrogate indicator for the outbreak response challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. Changes in childhood vaccination coverage over time in the Democratic Republic of the Congo.
- Author
-
Alfonso, Vivian H., Bratcher, Anna, Ashbaugh, Hayley, Doshi, Reena, Gadoth, Adva, Hoff, Nicole, Mukadi, Patrick, Ghanem, Angie, Cheng, Alvan, Gerber, Sue, Mwamba, Guillaume Ngoie, Muyembe Tamfum, Jean Jacques, Okitolonda Wemakoy, Emile, and Rimoin, Anne W.
- Subjects
VACCINATION ,VACCINATION of children ,DEMOGRAPHIC surveys ,CHILDREN ,IMMUNIZATION - Abstract
Despite increased vaccination rates, the burden, morbidity and mortality associated with vaccine preventable diseases remains high. In the Democratic Republic of the Congo (DRC), potentially unreliable data and geographically varied program provision call for a better understanding of vaccination coverage and its changes over time at the country and province level. To assess changes in the proportion of children who were fully vaccinated over time in the DRC, vaccination histories for children 12–59 months of age were obtained from both the 2007 and 2013–2014 Demographic and Health Surveys (DHS). Changes were assessed, both at the country- and province-levels, to identify potential geographic variations. Vaccination coverage improved 70% between the DHS waves: 26% compared to 44% of 12–59 month-old children met full vaccination criteria in 2007 and 2013–2014, respectively (n
2007 = 3032 and n2013-14 = 6619). Similarly, there was an overall trend across both DHS waves where as year of birth increased, so did vaccination coverage. There was geographic variation in immunization changes with most central and eastern provinces increasing in coverage and most northern, western and southern provinces having decreased vaccination coverage at the second time point. Using nationally representative data, we identified significant changes over time in vaccination coverage which may help to inform future policy, interventions and research to improve vaccination rates among children in the DRC. This study is the first of its kind for the population of DRC and provides an important initial step towards better understanding trends in vaccination coverage over time. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
12. Neurological, Cognitive, and Psychological Findings Among Survivors of Ebola Virus Disease From the 1995 Ebola Outbreak in Kikwit, Democratic Republic of Congo: A Cross-sectional Study.
- Author
-
Kelly, J Daniel, Hoff, Nicole A, Spencer, D'Andre, Musene, Kamy, Bramble, Matthew S, McIlwain, David, Okitundu, Daniel, Porco, Travis C, Rutherford, George W, Glymour, M Maria, Bjornson, Zach, Mukadi, Patrick, Okitolonda-Wemakoy, Emile, Nolan, Garry P, Muyembe-Tamfum, Jean Jacques, and Rimoin, Anne W
- Subjects
COGNITION disorder risk factors ,FAMILIES & psychology ,CONFIDENCE intervals ,EBOLA virus disease ,DISEASE outbreaks ,EVALUATION of medical care ,NEUROLOGIC examination ,NEUROLOGIC manifestations of general diseases ,PHYSICAL diagnosis ,QUESTIONNAIRES ,REGRESSION analysis ,CROSS-sectional method ,DISEASE complications ,DISEASE risk factors - Abstract
Background Clinical sequelae of Ebola virus disease (EVD) have not been described more than 3 years postoutbreak. We examined survivors and close contacts from the 1995 Ebola outbreak in Kikwit, Democratic Republic of Congo (DRC), and determined prevalence of abnormal neurological, cognitive, and psychological findings and their association with EVD survivorship. Methods From August to September 2017, we conducted a cross-sectional study in Kikwit, DRC. Over 2 decades after the EVD outbreak, we recruited EVD survivors and close contacts from the outbreak to undergo physical examination and culturally adapted versions of the Folstein mini-mental status exam (MMSE) and Goldberg anxiety and depression scale (GADS). We estimated the strength of relationships between EVD survivorship and health outcomes using linear regression models by comparing survivors versus close contacts, adjusting for age, sex, educational level, marital status, and healthcare worker status. Results We enrolled 20 EVD survivors and 187 close contacts. Among the 20 EVD survivors, 4 (20%) reported at least 1 abnormal neurological symptom, and 3 (15%) had an abnormal neurological examination. Among the 187 close contacts, 14 (11%) reported at least 1 abnormal neurologic symptom, and 9 (5%) had an abnormal neurological examination. EVD survivors had lower mean MMSE and higher mean GADS scores as compared to close contacts (MMSE: adjusted coefficient: −1.85; 95% confidence interval [CI]: −3.63, −0.07; GADS: adjusted coefficient: 3.91; 95% CI: 1.76, 6.04). Conclusions EVD survivors can have lower cognitive scores and more symptoms of depression and anxiety than close contacts more than 2 decades after Ebola virus outbreaks. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
13. Projections of Ebola outbreak size and duration with and without vaccine use in Équateur, Democratic Republic of Congo, as of May 27, 2018.
- Author
-
Kelly, J. Daniel, Worden, Lee, Wannier, S. Rae, Hoff, Nicole A., Mukadi, Patrick, Sinai, Cyrus, Ackley, Sarah, Chen, Xianyun, Gao, Daozhou, Selo, Bernice, Mossoko, Mathais, Okitolonda-Wemakoy, Emile, Richardson, Eugene T., Rutherford, George W., Lietman, Thomas M., Muyembe-Tamfum, Jean Jacques, Rimoin, Anne W., and Porco, Travis C.
- Subjects
VACCINES ,EBOLA virus disease ,GRAPHICAL projection ,FORECASTING ,BRANCHING processes ,EBOLA virus - Abstract
As of May 27, 2018, 6 suspected, 13 probable and 35 confirmed cases of Ebola virus disease (EVD) had been reported in Équateur Province, Democratic Republic of Congo. We used reported case counts and time series from prior outbreaks to estimate the total outbreak size and duration with and without vaccine use. We modeled Ebola virus transmission using a stochastic branching process model that included reproduction numbers from past Ebola outbreaks and a particle filtering method to generate a probabilistic projection of the outbreak size and duration conditioned on its reported trajectory to date; modeled using high (62%), low (44%), and zero (0%) estimates of vaccination coverage (after deployment). Additionally, we used the time series for 18 prior Ebola outbreaks from 1976 to 2016 to parameterize the Thiel-Sen regression model predicting the outbreak size from the number of observed cases from April 4 to May 27. We used these techniques on probable and confirmed case counts with and without inclusion of suspected cases. Probabilistic projections were scored against the actual outbreak size of 54 EVD cases, using a log-likelihood score. With the stochastic model, using high, low, and zero estimates of vaccination coverage, the median outbreak sizes for probable and confirmed cases were 82 cases (95% prediction interval [PI]: 55, 156), 104 cases (95% PI: 58, 271), and 213 cases (95% PI: 64, 1450), respectively. With the Thiel-Sen regression model, the median outbreak size was estimated to be 65.0 probable and confirmed cases (95% PI: 48.8, 119.7). Among our three mathematical models, the stochastic model with suspected cases and high vaccine coverage predicted total outbreak sizes closest to the true outcome. Relatively simple mathematical models updated in real time may inform outbreak response teams with projections of total outbreak size and duration. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
14. Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo.
- Author
-
Hoff, Nicole A, Mukadi, Patrick, Doshi, Reena H, Bramble, Matthew S, Lu, Kai, Gadoth, Adva, Sinai, Cyrus, Spencer, D'Andre, Nicholson, Bradley P, Williams, Russell, Mossoko, Matthias, Ilunga-Kebela, Benoit, Wasiswa, Joseph, Okitolonda-Wemakoy, Emile, Alfonso, Vivian H, Steffen, Imke, Muyembe-Tamfum, Jean-Jacques, Simmons, Graham, and Rimoin, Anne W
- Abstract
Healthcare settings have played a major role in propagation of Ebola virus (EBOV) outbreaks. Healthcare workers (HCWs) have elevated risk of contact with EBOV-infected patients, particularly if safety precautions are not rigorously practiced. We conducted a serosurvey to determine seroprevalence against multiple EBOV antigens among HCWs of Boende Health Zone, Democratic Republic of the Congo, the site of a 2014 EBOV outbreak. Interviews and specimens were collected from 565 consenting HCWs. Overall, 234 (41.4%) of enrolled HCWs were reactive to at least 1 EBOV protein: 159 (28.1%) were seroreactive for anti-glycoprotein immunoglobulin G (IgG), 89 (15.8%) were seroreactive for anti-nucleoprotein IgG, and 54 (9.5%) were VP40 positive. Additionally, sera from 16 (2.8%) HCWs demonstrated neutralization capacity. These data demonstrate that a significant proportion of HCWs have the ability to neutralize virus, despite never having developed Ebola virus disease symptoms, highlighting an important and poorly documented aspect of EBOV infection and progression. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
- Author
-
Mulangu, Sabue, Alfonso, Vivian H., Hoff, Nicole A., Doshi, Reena H., Mulembakani, Prime, Kisalu, Neville K., Okitolonda-Wemakoy, Emile, Kebela, Benoit Ilunga, Marcus, Hadar, Shiloach, Joseph, Je-Nie Phue, Wright, Linda L., Muyembe-Tamfum, Jean-Jacques, Sullivan, Nancy J., Rimoin, Anne W., and Phue, Je-Nie
- Subjects
SERODIAGNOSIS ,SEROPREVALENCE ,EBOLA virus ,EBOLA virus disease prevention ,PUBLIC health ,AGE distribution ,BEHAVIOR ,EBOLA virus disease ,EPIDEMIOLOGICAL research ,IMMUNOGLOBULINS ,POPULATION geography ,RURAL population ,SEX distribution ,VIRAL antibodies ,ENVIRONMENTAL exposure ,HUMAN research subjects - Abstract
Background: Previous studies suggest that cases of Ebola virus disease (EVD) may go unreported because they are asymptomatic or unrecognized, but evidence is limited by study designs and sample size.Methods: A large population-based survey was conducted (n = 3415) to assess animal exposures and behaviors associated with Ebolavirus antibody prevalence in rural Kasai Oriental province of the Democratic Republic of Congo (DRC). Fourteen villages were randomly selected and all healthy individuals ≥1 year of age were eligible.Results: Overall, 11% of subjects tested positive for Zaire Ebolavirus (EBOV) immunoglobulin G antibodies. Odds of seropositivity were higher for study participants older than 15 years of age and for males. Those residing in Kole (closer to the outbreak site) tested positive at a rate 1.6× higher than Lomela, with seropositivity peaking at a site located between Kole and Lomela. Multivariate analyses of behaviors and animal exposures showed that visits to the forest or hunting and exposure to rodents or duikers predicted a higher likelihood of EBOV seropositivity.Conclusions: These results provide serologic evidence of Ebolavirus exposure in a population residing in non-EBOV outbreak locations in the DRC and define statistically significant activities and animal exposures that associate with EBOV seropositivity. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
16. Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo.
- Author
-
Hoff, Nicole, Morier, Douglas, Kisalu, Neville, Johnston, Sara, Doshi, Reena, Hensley, Lisa, Okitolonda-Wemakoy, Emile, Muyembe-Tamfum, Jean, Lloyd-Smith, James, and Rimoin, Anne
- Subjects
VARICELLA-zoster virus diseases ,MIXED infections ,MONKEYPOX ,DISEASE incidence ,WATCHFUL waiting ,SOCIODEMOGRAPHIC factors - Abstract
From 2006 to 2007, an active surveillance program for human monkeypox (MPX) in the Democratic Republic of the Congo identified 151 cases of coinfection with monkeypox virus and varicella zoster virus from 1158 suspected cases of human MPX (13%). Using clinical and socio-demographic data collected with standardized instruments by trained, local nurse supervisors, we examined a variety of hypotheses to explain the unexpectedly high proportion of coinfections among the sample, including the hypothesis that the two viruses occur independently. The probabilities of disease incidence and selection necessary to yield the observed sample proportion of coinfections under an assumption of independence are plausible given what is known and assumed about human MPX incidence. Cases of human MPX are expected to be underreported, and more coinfections are expected with improved surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
17. Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
- Author
-
Bratcher, Anna, Hoff, Nicole A., Doshi, Reena H., Gadoth, Adva, Halbrook, Megan, Mukadi, Patrick, Musene, Kami, Ilunga-Kebela, Benoit, Spencer, D'Andre, Bramble, Matthew S., McIlwain, David, Kelly, J. Daniel, Mukadi, Daniel, Kingebeni, Placide Mbala, Ahuka, Steve, Okitolonda-Wemakoy, Emile, -Jacques Muyembe-Tamfum, Jean, and Rimoin, Anne W.
- Subjects
EBOLA virus disease ,EBOLA virus ,VIRAL antibodies ,SEROPREVALENCE ,Q fever ,TULAREMIA - Abstract
The correct name is: David McIlwain. Reference 1 Bratcher A, Hoff NA, Doshi RH, Gadoth A, Halbrook M, Mukadi P, et al. (2021) Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.